KATIE IRELAND: Open Payments
NPI 1861806549 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$158 in 7 payments from 5 companies in 2025. Trend: 2023 $398 · 2024 $430 · 2025 $158
Food & beverage: $158
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Exeltis, USA Inc. | 1 | $44 |
| Lilly USA, LLC | 2 | $35 |
| ABBVIE INC. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: MYFEMBREE, SLYND, LILETTA, MOUNJARO, ZEPBOUND, Veozah.
Industry payments across NY — which companies pay providers there.
